Empery Asset Management, LP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Empery Asset Management, LP has filed 470 SEC EDGAR filings since 31 Jul 2009

SEC filing history

Showing 76-100 of 467 matching filings.

Per page
25
Current page
4
SC 13G

NUVVE HOLDING CORP.

Filing date
09 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

X4 PHARMACEUTICALS, INC.

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

KIROMIC BIOPHARMA, INC.

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

REDHILL BIOPHARMA LTD.

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PERMEX PETROLEUM CORP

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

REDHILL BIOPHARMA LTD.

Filing date
13 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

X4 PHARMACEUTICALS, INC.

Filing date
13 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

VOLCON, INC.

Filing date
13 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PERMEX PETROLEUM CORP.

Filing date
12 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

KIROMIC BIOPHARMA, INC.

Filing date
12 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

DIRECT DIGITAL HOLDINGS, INC.

Filing date
12 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

ISPECIMEN INC.

Filing date
12 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-21771

13F-HR filing

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-21771

13F-HR filing

Filing date
12 Aug 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-21771

13F-HR filing

Filing date
16 May 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

DIRECT DIGITAL HOLDINGS, INC.

Filing date
18 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-21771

13F-HR filing

Filing date
11 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

TITAN PHARMACEUTICALS, INC.

Filing date
24 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

KIORA PHARMACEUTICALS, INC.

Filing date
24 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ISPECIMEN INC.

Filing date
24 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

1847 GOEDEKER INC.

Filing date
24 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

BIT BROTHER LTD.

Filing date
24 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PERASO INC.

Filing date
20 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PYXIS TANKERS INC.

Filing date
20 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

PHIO PHARMACEUTICALS CORP.

Filing date
20 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .